(Q38204539)

31 August 2017

title

Adipokines in gestational diabetes (English)

1 reference

31 August 2017

0 references

2

Matthias Blüher

1 reference

31 August 2017

1

Mathias Fasshauer

1 reference

31 August 2017

3

Michael Stumvoll

1 reference

31 August 2017

publication date

30 December 2013

1 reference

The Lancet: Diabetes & Endocrinology

31 August 2017

published in

1 reference

31 August 2017

volume

2

1 reference

31 August 2017

issue

6

1 reference

31 August 2017

page(s)

488-499

1 reference

Gestational diabetes mellitus

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Previous gestational diabetes mellitus and markers of cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Genetics in gestational diabetes mellitus: association with incidence, severity, pregnancy outcome and response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Adipokines and adipocyte targets in the future management of obesity and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Relative hypoleptinaemia in women with mild gestational diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Evaluation of the serum leptin in normal pregnancy and gestational diabetes mellitus in Zahedan, southeast Iran

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Third trimester plasma adiponectin and leptin in gestational diabetes and normal pregnancies.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Adipocytokines and insulin resistance across various degrees of glucose tolerance in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Maternal pregravid weight is the primary determinant of serum leptin and its metabolic associations in pregnancy, irrespective of gestational glucose tolerance status.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Gestational diabetes is associated with depressed adiponectin levels

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Serum retinol-binding protein 4 (RBP4) and retinol in a cohort of borderline obese women with and without gestational diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Gestational diabetes is associated with high energy and saturated fat intakes and with low plasma visfatin and adiponectin levels independent of prepregnancy BMI

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Maternal plasma leptin levels and their relationship to insulin and glucose in gestational-onset diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Increased plasma leptin in gestational diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Independent association between leptin and blood pressure during third trimester in normal and gestational diabetic pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Modulation of adipokines and cytokines in gestational diabetes and macrosomia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Assessment of insulin sensitivity/resistance and their relations with leptin concentrations and anthropometric measures in a pregnant population with and without gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Peripartum serum leptin and soluble leptin receptor levels in women with gestational diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Maternal serum leptin concentration in gestational diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Circulating concentrations of adiponectin and tumor necrosis factor-alpha in gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Maternal serum adiponectin concentration in gestational diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Maternal and cord blood adiponectin multimeric forms in gestational diabetes mellitus: a prospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Comparative analysis of adiponectin isoform distribution in pregnant women with gestational diabetes mellitus and after delivery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Zinc-α2-glycoprotein is unrelated to gestational diabetes: anthropometric and metabolic determinants in pregnant women and their offspring

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Arterial stiffness, inflammatory and pro-atherogenic markers in gestational diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Screening for biomarkers predictive of gestational diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Can adiponectin predict gestational diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Longitudinal changes of adiponectin, carbohydrate and lipid metabolism in pregnant women at high risk for gestational diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Association of retinol binding protein 4 with risk of gestational diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Maternal serum retinol-binding protein-4 at 11-13 weeks' gestation in normal and pathological pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Maternal serum resistin at 11 to 13 weeks' gestation in normal and pathological pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Leptin signaling and leptin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Activated translation signaling in placenta from pregnant women with gestational diabetes mellitus: possible role of leptin.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Dysregulation of leptin and testosterone production and their receptor expression in the human placenta with gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

The expression of suppressor of cytokine signaling 1 and 3 in fat and placental tissue from women with gestational diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Effects of gestational diabetes mellitus on proteins implicated in insulin signaling in human placenta.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Molecular mechanisms of diabetes and atherosclerosis: role of adiponectin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Review: Adiponectin--the missing link between maternal adiposity, placental transport and fetal growth?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Placental adiponectin gene DNA methylation levels are associated with mothers' blood glucose concentration

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

The role of adipokines in β-cell failure of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

TNF-alpha and adipocyte biology

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

TNF-alpha is a predictor of insulin resistance in human pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Placental effects of systemic tumour necrosis factor-α in an animal model of gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Determination of cytokine mRNA-expression in term human placenta of patients with gestational hypertension, intrauterine growth retardation and gestational diabetes mellitus using polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Gestational diabetes induces placental genes for chronic stress and inflammatory pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

RBP4: a controversial adipokine

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Retinol-binding protein 4 in adipose and placental tissue of women with gestational diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Resistin: functional roles and therapeutic considerations for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Resistin is expressed in the human placenta

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Visfatin in gestational diabetes: serum level and mRNA expression in fat and placental tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

The effects of pre–B-cell colony–enhancing factor on the human fetal membranes by microarray analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Vaspin in obesity and diabetes: pathophysiological and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Chemerin: a potential endocrine link between obesity and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Cord blood chemerin: differential effects of gestational diabetes mellitus and maternal obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Increased chemerin concentrations in fetuses of obese mothers and correlation with maternal insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Progranulin: at the interface of neurodegenerative and metabolic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Expression pattern of progranulin in the human placenta and its effect on cell proliferation in the choriocarcinoma cell line BeWo

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in obesity in mice and in humans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Quantitative analysis of matrix metalloproteinases-2 and -9, and their tissue inhibitors-1 and -2 in human placenta throughout gestation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Intra-amniotic infection upregulates neutrophil gelatinase-associated lipocalin (NGAL) expression at the maternal-fetal interface at term: implications for infection-related preterm birth

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Zinc-α2-glycoprotein: an adipokine modulator of body fat mass?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Apelin, diabetes, and obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Plasma apelin levels and apelin/APJ mRNA expression in patients with gestational diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Omentin: a novel link between inflammation, diabesity, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Omentin-1 is decreased in maternal plasma, placenta and adipose tissue of women with pre-existing obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Molecular Characteristics of Serum Visfatin and Differential Detection by Immunoassays

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

Adipokines in inflammation and metabolic disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970176-1

7 January 2021

10.1016/S2213-8587(13)70176-1

Identifiers

DOI

1 reference

31 August 2017

1 reference